Journal
NANOIMPACT
Volume 25, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.impact.2022.100385
Keywords
Nanoparticles; Nanoform; Safer by design; Risk assessment; Life cycle assessment; Nano-enabled products; Nanoscience
Funding
- Horizon 2020 Framework Programme of the European Union [646221]
- NanoReg2 consortium
- FFIKA, Focused Research Effort on Chemicals in the Working Environment, from the Danish Government
Ask authors/readers for more resources
Expectations for safer and sustainable chemicals and products are increasing, and this article introduces the application of Safe(r) by Design (SbD) in nanotechnology. The SbD approach aims to assess and balance functionality, human health and safety, environmental and economic impact, and cost as early as possible in the innovation process. The article also presents guidelines on the practical application of SbD based on the experience from the EU H2020 NanoReg2 project.
Expectations for safer and sustainable chemicals and products are growing to comply with the United Nations and European strategies for sustainability. The application of Safe(r) by Design (SbD) in nanotechnology implies an iterative process where functionality, human health and safety, environmental and economic impact and cost are assessed and balanced as early as possible in the innovation process and updated at each step. The EU H2020 NanoReg2 project was the first European project to implement SbD in six companies handling and/or manufacturing nanomaterials (NMs) and nano-enabled products (NEP). The results from this experience have been used to develop these guidelines on the practical application of SbD. The SbD approach foresees the identification, estimation, and reduction of human and environmental risks as early as possible in the development of a NM or NEP, and it is based on three pillars: (i) safer NMs and NEP; (ii) safer use and end of life and (iii) safer industrial production. The presented guidelines include a set of information and tools that will help deciding at each step of the innovation process whether to continue, apply SbD measures or carry out further tests to reduce uncertainty. It does not intend to be a prescriptive protocol where all suggested steps have to be followed to achieve a SbD NM/NEP or process. Rather, the guidelines are designed to identify risks at an early state and information to be considered to identify those risks. Each company adapts the approach to its specific needs and circumstances as company decisions influence the way forward.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available